Ajanta Pharma (BOM:532331) YoY EBITDA Growth : 71.41% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ajanta Pharma's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 71.41%.

Ajanta Pharma's EBITDA per Share for the three months ended in Mar. 2024 was ₹24.91.

Ajanta Pharma YoY EBITDA Growth Historical Data

The historical data trend for Ajanta Pharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma YoY EBITDA Growth Chart

Ajanta Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

32.46

33.06

2.75

-14.60

44.88

Ajanta Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-20.45	21.17	34.06	62.92	71.41

Ajanta Pharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ajanta Pharma's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(99.717	-	68.829)	/	\| 68.829 \|
=	44.88 %

Ajanta Pharma's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(24.908	-	14.531)	/	\| 14.531 \|
=	71.41 %

Ajanta Pharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Ajanta Pharma (BOM:532331) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

AJANTPHARM:India

Address

Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067

Website

https://www.ajantapharma.com

Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines